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Postoperative infection associated with polyester
patch angioplasty after carotid endarterectomy
Caron B. Rockman, MD,a William T. Su, MD,a Christopher Domenig, MD,b Patrick J. Lamparello,
MD,a Mark A. Adelman, MD,a Glenn R. Jacobowitz, MD,a Frank B. Pomposelli, MD,b and Thomas S.
Riles, MD,a New York, NY; and Boston, Mass
Objectives: Postoperative infection is one of the most dreaded complications associated with use of synthetic patches for
carotid endarterectomy. Although polyester patches were used extensively for carotid patch angioplasty throughout the
last decade, few reports detail cases of deep patch infection. We describe our experience with polyester patch infections
after carotid endarterectomy.
Patients and Methods: From January 1996 through December 2001 we treated polyester patch infections after carotid
endarterectomy in 10 patients.
Results: The interval from primary carotid endarterectomy to presentation with infection ranged from 11 days to 30
months. All patients underwent repeat operation that involved tissue debridement, excision of the polyester patch, and
either interposition grafting or patch angioplasty with autologous vein. No perioperative stroke or death occurred;
however, 1 patient had transient hoarseness, and in 1 patient a pseudoaneurysm developed that required additional
surgical repair with a saphenous vein interposition graft. All patients remain well and free of infection with follow-up as
long as 56 months.
Conclusions: Infection is a serious and rare complication of carotid patch angioplasty with polyester material. Nonetheless,
it can be treated successfully with good results and acceptable morbidity with soft tissue debridement, prosthetic patch
excision, and either patch angioplasty or interposition grafting with autologous vein. (J Vasc Surg 2003;38:251-6.)
Patch angioplasty is an accepted and widely used tech-
nique for improving the outcome of carotid endarterec-
tomy (CEA).1 However, the choice of optimal patch ma-
terial continues to be a topic of considerable debate among
vascular surgeons. Materials used for carotid patch angio-
plasty include autologous vein, polytetraflouroethylene
(PTFE), polyester, and bovine pericardium.
Autologous vein is usually harvested from the greater
saphenous vein in the thigh, although use of saphenous
vein from the ankle region, internal jugular vein, and cer-
vical veins has also been described.While vein has long been
considered the optimal standard for arterial vascular bypass
grafting elsewhere in the arterial tree, concerns have arisen
regarding use of saphenous vein for carotid reconstruction.
Specifically, reports of late aneurysm dilation, pseudoaneu-
rysm formation, and vein patch rupture have led to inves-
tigations for alternative acceptable patch materials.2-8 Har-
vest site morbidity and the need for venous conduits for
subsequent coronary or lower extremity revascularization
have also been cited as reasons to consider prosthetic patch
options.5,9
Prosthetic patches such as PTFE and knitted polyester
are attractive alternatives to vein because they are readily
available, technically easy to use, and may reduce risk for
rupture or aneurysm dilation. Knitted polyester is essen-
tially equivalent to vein in terms of perioperative morbidity
and recurrent carotid stenosis.9-11 Potential drawbacks to
prosthetic materials include possible increase in thrombo-
genicity and infection.12,13
While potential infectious complications remain a sig-
nificant concern, the literature contains few reports of
infected prosthetic patch infection after CEA. However,
several recent case series of carotid prosthetic patch infec-
tions have been reported and analyzed.14,15
Because of the potential seriousness of carotid patch
graft infection and because relatively few cases have been
reported in the literature, we offer an analysis of our expe-
rience in treatment of knitted polyester patch graft infec-
tions following routine CEA in 10 patients.
PATIENTS AND METHODS
From computerized databases maintained for all pa-
tients undergoing cerebrovascular surgery in the Divisions
of Vascular Surgery at the New York University Medical
Center (NYUMC) and Beth Israel Deaconess Medical
Center (BIDMC), records for all patients undergoing ca-
rotid surgery from January 1996 through December 2001
were reviewed. During this time, 2418 patients underwent
2717 primary carotid endarterectomies with knitted poly-
ester patch angioplasty. Ten patients were identified who
underwent surgery during the same period to treat pros-
thetic patch infection. No patients with carotid patch infec-
tion were treated nonsurgically.
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At NYUMC the standard protocol for CEA includes
cervical block anesthesia in most patients, shunt placement
when carotid clamping is not tolerated or when general
anesthesia is used, and plication in cases of carotid redun-
dancy. General anesthesia with routine shunting and very
selective use of cervical block anesthesia is the preferred
approach at BIDMC. Routine patch angioplasty with knit-
ted collagen-impregnated polyester material is the standard
protocol at both institutions. Prophylactic antibiotic ther-
apy was administered preoperatively and for 24 hours post-
operatively. The standard perioperative antibiotic is cefazo-
lin; vancomycin is used in patients with a history of severe
penicillin allergy.
RESULTS
Of the 10 patients operated on to treat polyester ca-
rotid patch infections, 9 underwent primary CEA at
NYUMC or BIDMN and 1 patient underwent initial sur-
gery at another institution.
Details of patient demographics and of the original
carotid surgery are presented in Table I. The study group
included 3men and 7 women, ranging in age from 57 to 84
years. Four patients had diabetes; 1 patient was insulin-
dependent. One patient with diabetes was additionally
receiving chronic immunosuppressive therapy with pred-
nisone because of temporal arteritis. One patient abused
alcohol. With the possible exception of the patient taking
prednisone, none of the other patients had any findings
suggestive of immunosuppression. No patient had any
known concomitant infectious process at the time of the
original surgery or in the perioperative period. All patients
received appropriate perioperative antibiotic therapy at the
time of the initial operation. The operative wounds were
closed without drainage, no patients had a significant he-
matoma or other problem necessitating repeat operation.
Details of the symptoms at presentation and workup of
the patch infection are presented in Table II. The interval
between initial surgery and presentation with a patch infec-
tion ranged from 11 days to 30 months. In 6 patients
infection developed relatively acutely (11 days-3 months),
whereas in 4 patients onset of infection was delayed (12-31
months). No patients had a history of concomitant infec-
tious process or invasive dental procedure before develop-
ment of infection. Patients with acute infection generally
had cellulitis and abscesses, whereas those with delayed
infection most commonly had draining sinus tracts.
Workup included a variety of tests, at the discretion of the
treating physician, including computed tomography (CT),
duplex ultrasound (US) scanning, magnetic resonance im-
aging (MRI), magnetic resonance angiography (MRA),
and conventional cerebral angiography. Three patients had
evidence of pseudoaneurysm formation on preoperative
imaging studies.
Details of management of the repeat operative proce-
dure and bacteriologic findings are presented in Table III.
Orotracheal intubation was used in all operations, and no
repeat operations required unusual procedures, eg, man-
dibular subluxation, to achieve distal arterial access and
control. Transection of the omohyoid or posterior digastric
muscles was performed at surgeon discretion. All patients
underwent extensive soft tissue and arterial debridement,
complete polyester patch removal, and wound irrigation
with antibiotic solution. The arterial defect was repaired
with a vein patch graft in 8 patients; however, the other 2
patients had extensive involvement of the arterial wall and
required an interposition vein graft. No patient underwent
Table I. Patient demographics and details of original carotid surgery
Patient
Age
(y) Sex
Diabetes
mellitus Immunosuppression
Antibiotic
used
Time of
antibiotic
administration Anesthesia
Shunt
used Complication
1 70 F Yes Cefazolin In OR before
incision
General Yes None
2 73 F Yes Cefazolin In OR before
incision
Regional No None
3 73 F Yes Vanocomycin In OR before
incision
General Yes None
4 57 M No Cefazolin In OR before
incision
Regional Yes None
5 81 M No Chronic alcohol abuse Cefazolin In OR before
incision
Regional No None
6 75 F No Cefazolin In OR before
incision
General Yes None
7 73 F No Cefazolin In OR before
incision
Regional No None
8 80 F Yes Chronic steroid therapy Cefazolin In OR before
incision
Regional No None
9 65 M No Cefazolin In OR before
incision
Regional No None
10 84 F No Cefazolin In OR before
incision
General Yes None
OR, Operating room.
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internal carotid artery ligation. Drains were not routinely
used.
There were no instances of perioperative stroke, death,
or permanent cranial nerve injury. One patient had tran-
sient postoperative hoarseness, which resolved after 2
months. In 1 patient who underwent vein patch angio-
plasty to treat the initial infection a sterile pseudoaneurysm
developed 1 month after surgery. This required a second
repeat operation and repair with a vein interposition graft.
Infectious organisms identified included Staphylococcus
aureus, Staphylococcus epidermidis, Streptococcus viridans,
Bacteroides fragilis, Pseudomonas aeruginosa, Proteus mira-
Table II. Details of presentation and workup of prosthetic patch infections
Patient
Interval to
presentation Symptoms
Clinical
sepsis Tests performed Test results Pseudoaneurysm Comments
1 11 d Hematoma,
cellulitis
No Duplex US scanning Pseudoaneurysm on
duplex US scan
Yes
2 2 wk Cellulitis,
abscess
Yes CT Abscess No
3 2 wk Cellulitis,
abscess
Yes None No Returned to OR without
diagnostic tests
4 3 wk Cellulitis,
abscess
Yes CT Abscess No
5 3 wk Cellulitis,
abscess
Yes None No Returned to OR without
diagnostic tests
6 3 mo Draining
sinus
No Duplex US
scanning, MRA
Fluid around patch,
recurrent stenosis
Yes
7 12 mo Draining
sinus
No Duplex US
scanning, CT
Fluid around patch,
sinus tract
No
8 13 mo Draining
sinus
No CT Fistulous tract to
artery
No
9 24 mo Draining
sinus
No Duplex US
scanning, CT
Fluid collection,
inflammation
No Interim CT scan
obtained 1 year after
original surgery to
treat neck fullness
revealed possible fluid
collection
10 31 mo Draining
sinus
No CT, angiography Inflammatory
changes from
artery to skin on
CT scan, normal
angiogram
Yes
CT, Computed tomography; US, ultrasound, MRA, magnetic resonance angiography; OR, operating room.
Table III. Details of operative management and bacteriology of prosthetic patch infections
Patient Anesthesia Shunt
Patch
or
graft Material used
Perioperative
complications Bacteria isolated
Sensitive to
original
CEA
antibiotic Comments
1 General Yes Patch Saphenous vein Postoperative
pseudoaneurysm
Staphylococcus aureus No Required additional
surgery 6 weeks
postoperatively
2 General No Patch Saphenous vein Transient cranial
nerve injury
Streptococcus viridans,
Bacteroides fragilis
No
3 General Yes Patch Saphenous vein B fragilis No
4 General Yes Patch Saphenous vein S aureus No
5 General Yes Patch Internal jugular
vein
S viridans Yes
6 General Yes Patch Superficial
femoral vein
Bacterium acnes Unknown
7 General Yes Patch Saphenous vein S viridans, S
epidermidis
Unknown
8 General Yes Graft Saphenous vein S epidermis Yes
9 General Yes Patch Saphenous vein S epidermidis Yes
10 General Yes Graft Saphenous vein S epidermidis No
CEA, Carotid endarterectomy.
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bilis, and Bacterium acnes. Delayed infection tended to be
caused by S epidermidis, whereas more acute infections
harbored a variety of organisms. In 3 patients with gram-
positive infection, the organism cultured was sensitive to
cefazolin, which was used as a preoperative prophylactic
antibiotic at the original carotid surgery.
Details of postoperative antibiotic management and
follow-up are presented in Table IV. Postoperative antibi-
otic therapy was administered for 4 weeks to 11 months,
depending on the organisms involved. Choice of antibiotic
was determined with culture and sensitivity studies of the
operative wound, and consultation with an infectious dis-
ease specialist was obtained in all cases.
All patients have been followed up with periodic clinical
examination and duplex US scanning. At the time of this
report, there has been no recurrent infection during fol-
low-up of 8 to 56 months.
DISCUSSION
Reconstruction of the carotid artery after CEA may be
performed with either primary closure or patch angioplasty.
Potential advantages of patch angioplasty include decreas-
ing the incidence of postoperative thrombosis and emboli-
zation and of recurrent carotid stenosis. Although there is
no definitive evidence that patch angioplasty is preferable to
primary closure, several studies, including the Asymptom-
atic Carotid Atherosclerosis Study, have suggested the su-
periority of the patch angioplasty technique.16
The ideal material for patch angioplasty of the carotid
artery after CEA is unclear. Certainly the patient’s greater
saphenous vein has the advantages of being autologous,
readily available, and technically easy to use. However,
concerns have arisen after a number of reports of early
rupture of saphenous vein patches used for CEA.2-8 Al-
though rare, this complication can be devastating and may
result in stroke or death. O’Hara et al8 reported 8 patch
ruptures among 1691 CEA procedures in which saphenous
vein was used (0.5%). The incidence of stroke or death in
these cases was nearly 30%.Other concerns regarding use of
saphenous vein include possible development of late aneu-
rysm degeneration, complications related to the wound
harvest site, and need to preserve the vein for future periph-
eral arterial or coronary reconstruction. In addition, despite
use of autologous saphenous vein, severe infections of
patches with pseudoaneurysm formation have been re-
ported; autologous material is not immune to significant
infectious complications.2-4 Moreover, infected pseudoan-
eurysms of the carotid artery have been reported after CEA
with primary closure.17
A variety of synthetic materials, most commonly PTFE
and knitted polyester, have been used for patch angioplasty
after CEA. Synthetic patches have the potential advantages
of being readily available, reliable, and technically easy to
use. Harvest wound complications do not occur, and the
saphenous vein is preserved for future use. However, there
are concerns regarding increased thrombogenicity of syn-
thetic patches in the carotid position. In addition, infection
of a synthetic structure in this position is certainly a poten-
tially serious complication. Use of synthetic patches does
not increase risk for perioperative stroke or recurrent ste-
nosis after CEA.9-11
Infection involving synthetic carotid patches has not
been widely studied or reported; with the current report,
we add an additional 10 cases of synthetic carotid patch
infection to the existing literature of approximately 50
cases.14,15,18-23
Naylor et al,14 in a prospective series, reported an
incidence of 0.85% for prosthetic patch infection after CEA
(8 of 936 patients). In the current series the incidence is
approximately 0.3%, excluding the patient who underwent
primary carotid endarterectomy at another institution. Cer-
tainly we cannot be sure that patients operated on originally
at our institutions did not receive treatment for infection
elsewhere; however, this is unlikely. Although the exact
incidence of prosthetic patch infection is uncertain, it is
therefore probably extremely low. The above numbers are
comparable with rates reported in the literature for vein
patch rupture, which range from 0.1% to 4.0%.5-8 On the
basis of these small numbers, no firm conclusions can be
drawn; however, morbidity and mortality for vein patch
rupture is probably higher than that for prosthetic patch
infection. Although synthetic patch infection is indeed a
serious complication, results of our study show that it can
be managed successfully.
Table IV. Details of antibiotic management and follow-up
Patient
Oral antibiotic Intravenous antibiotic
Follow-up
(mo) Follow-up statusType
Duration
(wk) Type
Duration
(wk)
1 Levofloxacin 2 Levofloxacin 2 8 Alive and well
2 Trovafloxacin 4 Ceftriaxone 4 42 Alive and well
3 Metronidazole 4 Vancomycin, ceftazidime 10 days 56 Alive and well
4 Oxacillin 6 16 Alive and well
5 Cefazolin 6 8 Alive and well
6 Unclear Unclear 23 Alive and well
7 Amoxicillin/clavulanate 2 Vancomycin 1 20 Alive and well
8 Doxycycline 3 Vancomycin 1 11 Alive and well
9 Ceftriaxone 19 Alive and well
10 Vancomycin 4 8 Alive and well
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Etiologic factors that predispose to development of
patch infection are unclear. Certainly there was no clear-cut
cause for infection in any of the patients in our study. All
patients received appropriate perioperative antibiotic ther-
apy at the original CEA. Of the 10 patients reported, 4 had
diabetes, and 1 of these patients was additionally receiving
chronic steroid therapy; and 1 additional patient had a
history of alcohol abuse. No patients had a history of
concomitant dental or other infectious problem, either at
the original CEA or when the patch infection was diag-
nosed. However, no firm conclusions can be drawn from
these small numbers.
The diagnosis of carotid patch infectionmay be difficult
at times, because of the variety of symptoms caused by
different organisms. Acute infection tended to be obvious,
with presence of cellulitis and abscess formation. In gen-
eral, acute infection was caused bymore virulent organisms.
However, chronic infection caused by more indolent or-
ganisms, eg, S epidermidis, was often manifested by only a
small sinus tract without local or systemic signs of infection.
In such instances, deep infection is sometimes difficult to
diagnose, which can lead to extensive testing and conser-
vative therapy before definitive surgical treatment is under-
taken. A high index of suspicion is necessary for timely
diagnosis. Imaging studies used in our study included a
combination of duplex US scanning, CT, and MRA. Only
1 patient in this series underwent preoperative cerebral
angiography. Several patients with early obvious infection
and abscess were operated on without any preoperative
imaging studies. An aggressive surgical approach is war-
ranted at the time of diagnosis.
Traditional surgical treatment consists of wide debride-
ment of infected and necrotic tissue and complete removal
of all patch material. In this series, all operations were
performed with the patient under general anesthesia; al-
though dissection was occasionally difficult, all repeat op-
erations were accomplished without the need for nasotra-
cheal intubation or subluxation of the mandible. Options
for arterial reconstruction after excision and debridement
include carotid ligation, primary closure, patch angioplasty,
and interposition grafting. Carotid ligation is associated
with a postoperative stroke rate as high as 50% and should
be used only as a last option.17 Primary closure of the artery
at repeat operation would negate any benefit from angio-
plasty, especially in postdebridement vessels, which are
inherently smaller.
Our preferred method of arterial reconstruction is
patch angioplasty or interposition grafting with autologous
vein. If the 10 patients in our series are combined with the
additional 16 patients of Naylor et al14 and Rizzo et al,15 23
of 26 (88.5%) infected carotid arteries were able to be
reconstructed successfully with autologous material.
An alternative treatment for acute carotid prosthetic
patch infection has been described by Zacharoulis et al18
and Sternberghet al.20 To minimize the inherent risk for
stroke with repeat operative carotid surgery, these authors
opted for wound debridement and coverage with a sterno-
cleidomastoid flap without arterial reconstruction; this was
successful in 4 patients. This technique was only used in
selected patients with patent vessels, intact anastomoses,
and absence of systemic sepsis. Conservative therapy with
intravenous antibiotics only was described by Byer et al19 in
a patient with synthetic patch infection without abscess
formation. Their patient, with multiple medical comorbid
conditions, had cellulitis and extensive phlegmon around
the carotid artery, without signs of deeper abscess forma-
tion on CT images. Antibiotic treatment, initially instituted
to improve later surgical dissection and debridement, be-
came definitive therapy when the phlegmon rapidly re-
solved with conservative therapy alone. This is reported as
an exceptional case with successful short-term results but
uncertain long-term results, and such conservative therapy
is not advocated as an appropriate option in most cases.
One difference between the current series and other
reported cases relates to the bacteriology of the infections.
Almost invariably, previously reported cases of prosthetic
patch infection have revealed Staphylococcus species or
Streptococcus species. In the current report, 3 of 6 early
infections revealed unusual organisms: B fragilis in 2 cases
and B acnes in 1 case. Two of these patients with infection
caused by these unusual organisms had diabetes. All de-
layed infections were caused by S epidermidis. The reasons
for the presence of less common organisms in our series are
unclear.
Medical management of these infections includes ag-
gressive antibiotic therapy. Once the diagnosis of infection
is entertained, empiric broad-spectrum antibiotic therapy
should be started. Antibiotic therapy may be tailored when
specific culture results are obtained from the operating
room specimens or from sinus tract drainage. Duration of
intravenous antibiotic therapy in this series ranged from 1
to 6 weeks postoperatively. Additional oral antibiotic ther-
apy was used in most patients. No specific guidelines can be
formed from this experience. In each case, duration and
nature of antibiotic therapy was established after consulta-
tion with an infectious disease specialist and was based on
virulence of the responsible organism, severity of presenta-
tion of infection, presence of ongoing systemic sepsis, and
presence or absence of underlying immunosuppression.
Even with a variety of antibiotic regimens, all of our pa-
tients remain free of infection at the time of this report, ie,
8 to 56 months after surgery.
CONCLUSION
While the consequences of deep infection of a polyester
carotid artery patch can be serious, the problem can be
treated with reasonable success. The true incidence of
infection after prosthetic patch angioplasty during CEA is
unknown but is most likely low. The preferred treatment
for synthetic carotid patch infection is surgery, and involves
extensive debridement, removal of all synthetic material,
and autologous artery reconstruction. This approach has
led to successful results in 10 patients. Currently the pref-
erence at our institutions remains knitted polyester for
patch angioplasty during CEA. Further long-term studies
of the risks and complications associated with prosthetic
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patches will be necessary to determine their overall utility
compared with autogenous vein for carotid patch angio-
plasty.
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